Healthcare
Live Price
Offline$1.46
+0.00% today
1Y Change
-17.51%
Window
Jun 23, 2025 → Jun 5, 2026
Coverage: 246 bars · Jun 23, 2025 → Jun 5, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Vicapsys Life Sciences, Inc. (VICP) is a Healthcare stock with a market cap of $50.00M and listed on OTC. The stock last traded around $1.46 and down 17.5% across the available one-year price window (Jun 23, 2025 → Jun 5, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +32.3%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +32.3%, free cash flow +82.4% with operating margin 0.0% and ROIC 16.2%. Stock Foundry combines VICP price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VICP
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
VICP Max Drawdown
-91.53%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for VICP and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$765.8K
-223.3% YoY
Free Cash Flow
-$262.9K
+40.8% YoY
Revenue Growth
+0.0%
EPS Growth
+32.3%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | -31K | -31K | -31K |
| Operating Income | -814K | -1M | -985K | -337K | -766K |
| EBITDA | -900K | -1M | -613K | -306K | -734K |
| Net Income | -990K | -1M | -985K | -237K | -766K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | 12K | 9K | 14K | 217K | 1K |
| Total Assets | 12K | 40K | 72K | 594K | 404K |
| Total Liabilities | 3M | 2M | 1M | 716K | 853K |
| Shareholder Equity | -3M | -2M | -951K | -122K | -449K |
| Total Debt | 579K | 354K | 0 | 0 | 0 |
| Net Debt | 567K | 344K | -14K | -217K | -1K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
263K
+40.8% YoY
Capital Expenditures
0
-100.0% YoY
Free Cash Flow
263K
+40.8% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
14.1%
Debt / Equity
-0.19x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.